Diabetic Nephropathies

"Diabetic Nephropathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Descriptor ID	D003928
MeSH Number(s)	C12.777.419.192 C13.351.968.419.192 C19.246.099.875
Concept/Terms	Diabetic Nephropathies Diabetic Nephropathies Nephropathies, Diabetic Nephropathy, Diabetic Diabetic Nephropathy Diabetic Kidney Disease Diabetic Kidney Diseases Kidney Disease, Diabetic Kidney Diseases, Diabetic Diabetic Glomerulosclerosis Diabetic Glomerulosclerosis Kimmelstiel-Wilson Syndrome Kimmelstiel Wilson Syndrome Syndrome, Kimmelstiel-Wilson Kimmelstiel-Wilson Disease Kimmelstiel Wilson Disease Nodular Glomerulosclerosis Glomerulosclerosis, Nodular Glomerulosclerosis, Diabetic Intracapillary Glomerulosclerosis

Below are MeSH descriptors whose meaning is more general than "Diabetic Nephropathies".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Diabetic Nephropathies [C12.777.419.192]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Diabetic Nephropathies [C13.351.968.419.192]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Nephropathies [C19.246.099.875]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Nephropathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Nephropathies" by people in this website by year, and whether "Diabetic Nephropathies" was a major or minor topic of these publications.

Bar chart showing 35 publications over 14 distinct years, with a maximum of 4 publications in 2009 and 2012 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	2	3
2005	2	1	3
2008	0	1	1
2009	2	2	4
2010	2	0	2
2012	1	3	4
2014	1	1	2
2017	2	0	2
2018	2	0	2
2019	1	2	3
2020	1	0	1
2021	3	0	3
2022	1	0	1
2023	4	0	4

Below are the most recent publications written about "Diabetic Nephropathies" by people in Profiles.

Kim YH, Saha MK, Hu Y, Kumar S, Poulton CJ, Hogan SL, Nachman P, Jennette JC, Nast CC, Mottl AK. Impact of Diabetic Lesions on Pathology, Treatment, and Outcomes of Glomerular Diseases. Kidney360. 2023 10 01; 4(10):1445-1453.

View in: PubMed
Ferkowicz MJ, Verma A, Barwinska D, Melo Ferreira R, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):266-275.

View in: PubMed
Buckley LF, Schmidt IM, Verma A, Palsson R, Adam D, Shah AM, Srivastava A, Waikar SS. Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease. JAMA Cardiol. 2023 04 01; 8(4):357-365.

View in: PubMed
Liu G, Li Y, Pan A, Hu Y, Chen S, Qian F, Rimm EB, Manson JE, Stampfer MJ, Giatsidis G, Sun Q. Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes. JAMA Netw Open. 2023 01 03; 6(1):e2252239.

View in: PubMed
Braden GL, Landry DL. The Next Frontier: Biomarkers and Artificial Intelligence Predicting Cardiorenal Outcomes in Diabetic Kidney Disease. Kidney360. 2022 09 29; 3(9):1480-1483.

View in: PubMed
Cristancho C, Hemond CC. Serum Albumin Modifies the Effect of Peripheral Blood Monocytes on Severity of Diabetic Nephropathy in an Adult Population. Can J Diabetes. 2022 Feb; 46(1):69-74.

View in: PubMed
Patel AB, Mistry K, Verma A. DAPA-CKD: Significant Victory for CKD with or without Diabetes. Trends Endocrinol Metab. 2021 06; 32(6):335-337.

View in: PubMed
Verma A, Patel AB. Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease. Trends Endocrinol Metab. 2021 05; 32(5):261-263.

View in: PubMed
Verma A, Patel AB, Upadhyay A, Waikar SS. CREDENCE: Significant Victory for Diabetic Kidney Disease. Trends Endocrinol Metab. 2020 06; 31(6):391-393.

View in: PubMed
Hanrahan JP, Seferovic JP, Wakefield JD, Wilson PJ, Chickering JG, Jung J, Carlson KE, Zimmer DP, Frelinger AL, Michelson AD, Morrow L, Hall M, Currie MG, Milne GT, Profy AT. An exploratory, randomised, placebo-controlled, 14?day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension. Diabetologia. 2020 04; 63(4):733-743.

View in: PubMed

People

Explore

Similar Concepts

Top Journals